Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07143227
PHASE1

A Study of XW003 Injection in Chinese Adolescents With Obesity

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.

View on ClinicalTrials.gov

Summary

The aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XW003 injection in Chinese adolescents with obesity

Official title: A Randomized, Double-blind, Placebo-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of XW003 Injection in Chinese Adolescents With Obesity

Key Details

Gender

All

Age Range

12 Years - 18 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2025-08-25

Completion Date

2026-12-31

Last Updated

2026-01-28

Healthy Volunteers

Yes

Interventions

DRUG

XW003 injection

Subcutaneous injection

DRUG

placebo with matching volume

Subcutaneous injection

Locations (1)

Qilu Hospital of Shandong University

Jinan, Shandong, China